NAICS 541711 — Research And Development In Biotechnology
Contracts in this directory: 5. Total obligated: $14,209,665,003.41.
Federal contract awards with obligation activity November 9, 2023 – November 9, 2026. Data through November 9, 2026.
2 contracts in this NAICS code end in the next 12 months.
Contracts
| Recipient | Award ID (PIID) | Agency | NAICS | Obligated | Potential value | Ends | Source |
|---|---|---|---|---|---|---|---|
| Alliance For Energy Innovation, LLC | DEAC3608GO28308 | Department of Energy | 541711 | $11,311,227,063.57 | $13,302,204,581.00 | 2028-09-30 | USAspending |
| Emergent Product Development Gaithersburg Inc. | HHSO100201600030C | Department of Health and Human Services | 541711 | $1,409,725,727.10 | $1,457,346,257.10 | 2026-09-29 | USAspending |
| Regeneron Pharmaceuticals Inc. | HHSO100201700016C | Department of Health and Human Services | 541711 | $973,560,406.91 | $1,036,922,154.91 | 2031-09-29 | USAspending |
| Regeneron Pharmaceuticals Inc. | HHSO100201700020C | Department of Health and Human Services | 541711 | $278,844,171.83 | $359,611,757.83 | 2027-09-25 | USAspending |
| Merck Sharp & Dohme LLC | HHSO100201700012C | Department of Health and Human Services | 541711 | $236,307,634.00 | $291,370,929.00 | 2027-09-27 | USAspending |
| Total of all 5 contracts in this group | $14,209,665,003.41 | $16,447,455,679.84 | |||||
Showing the top 5 of 5 contracts in this group. Group total (all 5): $14,209,665,003.41 obligated, $16,447,455,679.84 potential value. The full list and CSV export come with the paid plan — see Pricing.